Subscribe To
Talon metals signs agreement with us doe for $114.8m in bipartisan infrastructure law funding
Talon Metals Corp. (TSX:TLO, OTC:TLOFF) told investors it has signed a definitive agreement with the US Department of Energy (DOE) setting the terms, ...
7 secret semiconductor stocks ready to grab the spotlight
Everyone knows the top semiconductor stocks to buy. Headliners like Nvidia (NASDAQ: NVDA ), Advanced Micro Devices (NASDAQ: AMD ), and Taiwain Semicon...
Pausing on palantir: why pltr stock is not worth the gamble today
Tech firm Palantir Technologies (NASDAQ: PLTR ) had a turbulent few years. On a year-to-date basis, PLTR stock has surged more than 130%....
Sedg stock plummets as multiple analysts downgrade solaredge
Solaredge Technologies (NASDAQ: SEDG ) stock is falling on Thursday after the company's shares were hit with multiple downgrades following its latest ...
Sainsbury's persistence on value now vital - analysts
Strong half-year trading for J Sainsbury PLC (LSE:SBRY) proves that the supermarket's strategic shift to quality coupled with value has started work, ...
Venezuela's october oil exports fall 19% despite u.s. easing sanctions
Venezuela's oil exports declined in October to less than 700,000 barrels per day (bpd) amid operational hiccups at the country's main production regio...
Is alphabet a buy?
Alphabet's revenue and earnings beat expectations, but cloud revenue was a disappointment. The business is positioning itself to be a clear leader in ...
Nrg energy misses revenue estimates
NRG Energy on Thursday missed Wall Street estimates for third-quarter revenues and reported lower contributions from its home services business and on...
Lucid diagnostics to present at canaccord genuity medtech, diagnostics, and digital health & services forum
Lishan Aklog, M.D., Chairman & CEO, to Present November 16, 2023, in New York NEW YORK , Nov. 2, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq...
In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta ...
Paypal gets a lift. why the stock could be too cheap to fail.
An earnings beat and new management are putting turnaround hopes front and center for the payments company....
Gold price forecast – gold markets recover slightly on thursday
Gold markets rallied just a bit during the trading session on Thursday, as it looks like we continue to flirt with the $2000 level....
Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition
BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today ...
At&t, verizon, or t-mobile: which telecom stock should you buy after earnings?
The three wireless carriers are all growing free cash flow faster than expected. Verizon and AT&T have heavier debt loads than T-Mobile, and those deb...
Sidus space awarded multi-million-dollar contract for commercial lunar transportation
Sidus Space Inc (NASDAQ:SIDU) announced that it has been awarded a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract, with a $10 mil...
Editas medicine to present clinical data from the ruby and edithal trials of edit-301 at the ash 2023 annual meeting and in a company-sponsored webinar
Company to host a webinar to discuss EDIT-301 clinical data on Monday, December 11, at 1:00 p.m. ET Dr. Rabi Hanna from Cleveland Clinic Children's to...
This stock has a 6.05% yield and sells for less than book
the recent Ford share price of $9.91 represents a price-to-book ratio of 0.9 and an annual dividend yield of 6.05%...
Building a sustainable portfolio: 3 esg stocks to buy and hold
At first, the idea of environmental, social and governance or ESG stocks to buy and hold doesn't seem particularly lucrative. Generally, an understand...
Vincerx pharma to present three posters at ash 2023 in december
VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...
Invest in the future: buy & hold visa, mcdonald's and microsoft forever
The uncertainty surrounding interest rates and the mixed earnings have pressured investor sentiment. With the holiday season upon us, now is also a go...
Ford reports lower us vehicle sales in october
Ford reported a 5.3% drop in total U.S. vehicle sales in October after the United Workers Union (UAW) staged walkouts at some of the company's plants ...
Ferrari again raises guidance as customers opt for high-priced, personalized sports cars
Ferrari raised guidance after its third-quarter profit surged 46% year over year. Its customers continue to load up their new Ferraris with expensive ...
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...
Baxter international beats q3 profit estimates on strong demand for medical devices
Baxter International on Thursday beat Wall Street expectations for third-quarter revenue and profit, as a recovery in surgical procedure volumes after...
A bullish storm is brewing for cloud stocks
Results from ServiceNow NASDAQ: NOW bode well for cloud services stocks. The company posted results that sparked a round of surprisingly bullish chatt...
Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition
– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease...
Electric truck maker nikola reports wider loss in third quarter
Nikola posted a wider loss in the third quarter on Thursday, after the electric truck maker suspended sales and recalled its battery-electric heavy du...
Big tech sell-off: will tesla be the next domino to fall?
Top Nasdaq stocks have undergone steep sell-offs. So far this year, Tesla's results have been worse than expected....
7 value stocks to buy while they are still out of the limelight
Although 2023 has witnessed a massive surge in relevant industries – most notably artificial intelligence – investors may want to consider value s...
A top meta scientist's claims ai won't wipe out humanity are dangerous, says his former co-researcher
AI godfather Yoshua Bengio says the risks of AI should not be underplayed. In an interview with Insider, Bengio criticized peers dismissing AI's t...
Mondelez (mdlz) ups view on q3 earnings beat: organic sales aid
Mondelez's (MDLZ) third-quarter 2023 results reflect strength across categories, brands and geographies. Management raises guidance for 2023....
Scotts miracle-gro (smg) q4 earnings & sales beat estimates
The decline in sales of Scotts Miracle-Gro (SMG) is due to lower sales in the U.S. Consumer and Hawthorne segments in Q4....
Medifast (med) queues for q3 earnings: what awaits the stock?
Medifast's (MED) third-quarter results are likely to reflect concerns surrounding customer acquisition amid a challenging landscape. However, a focus ...
Roku's q3 loss wider than expected, revenues increase y/y
ROKU's third-quarter 2023 results benefit from growing active accounts and streaming hours on The Roku Channel....